Volver al feed
FinanzasMarketWatch.com - Top StoriesJaimy Lee

Contenido en inglés

Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine

Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine

En resumen

The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.

Fuente primaria
— Leer artículo original
Publicado
Tema
Finanzas

The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.

Este resumen proviene de MarketWatch.com - Top Stories. Lee el artículo completo en la fuente original.

Referencias